MedAlliance SELUTION SLR Receives Second FDA IDE Approval
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GENEVA, Aug. 10, 2022 /PRNewswire-AsiaNet/ -- SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of occlusive disease of the superficial femor...
Authors: LATEST ASIANET NEWS RELEASES